Skip to Main Content

An official website of the United States government

Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit  cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

Use of Breast Cancer Risk Reducing Medications

Principal Investigator
Name
Paul Pinsky
Institution
National Institutes of Health
Position Title
Chief, EDRG
Email
About this CDAS Project
Study
PLCO (Learn more about this study)
Project ID
PLCO-1749
Initial CDAS Request Approval
Nov 19, 2024
Title
Use of Breast Cancer Risk Reducing Medications
Summary
Assess the use of breast cancer risk reducing medications by breast cancer risk, calendar year, and other factors.
Aims

Compute rates of breast cancer risk reducing medications by breast cancer risk level.

Compute rate of breast cancer risk reducing medications by calendar year

Collaborators

None

Related Publications